Skip to content
  • Friday, 14 August 2026
  • 11:28 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Measles Research Intensifies Amidst Declining Vaccination Rates: Scientists Explore Antiviral Treatments to Combat Resurgent Disease
Environmental & Analytical Chemistry

Measles Research Intensifies Amidst Declining Vaccination Rates: Scientists Explore Antiviral Treatments to Combat Resurgent Disease

Abdurrohim Arsyad Jun 15, 2026 0

The resurgence of measles, a highly contagious viral illness, is prompting a renewed focus on therapeutic interventions beyond vaccination. While…

Read More
Biotech & Genetic Research

Scientists Pioneer World’s First Human Antibody Treatment for Measles, Offering Critical Defense Amid Global Resurgence

Jia Lissa May 16, 2026 0

In a groundbreaking development that promises to reshape the global fight against measles, scientists at the La Jolla Institute for…

Read More
Biotech & Genetic Research

Scientists Uncover Potent Human Antibodies, Paving the Way for First-Ever Measles Treatment and Prevention

Jia Lissa May 8, 2026 0

Scientists at the La Jolla Institute for Immunology (LJI) in California have achieved a significant breakthrough, becoming the first in…

Read More
Mitochondrial Dysfunction Identified as Direct Cause of Dementia Symptoms in Breakthrough StudyArtificial Intelligence Deciphers the Hidden Molecular Architecture of Supercooled Water to Explain its Anomalous Physical PropertiesScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Snail-Inspired Soft Robots Poised to Revolutionize Precision Drug Delivery for Cancer and Beyond
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ